UG 📈 United-Guardian - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9105711082

UG: Cosmetics, Pharmaceuticals, Medical Lubricants, Industrial Products

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York. Web URL: https://www.u-g.com

Additional Sources for UG Stock

UG Stock Overview

Market Cap in USD 45m
Sector Consumer Defensive
Industry Household & Personal Products
GiC Sub-Industry Personal Care Products
IPO / Inception 1992-03-17

UG Stock Ratings

Growth 5y -26.9%
Fundamental 54.9%
Dividend 29.3%
Rel. Strength Industry 91.7
Analysts -
Fair Price Momentum 9.53 USD
Fair Price DCF 23.16 USD

UG Dividends

Dividend Yield 12m 6.20%
Yield on Cost 5y 3.86%
Annual Growth 5y -38.10%
Payout Consistency 89.9%

UG Growth Ratios

Growth Correlation 3m -88.7%
Growth Correlation 12m 83.2%
Growth Correlation 5y -47.2%
CAGR 5y -9.04%
CAGR/Mean DD 5y -0.23
Sharpe Ratio 12m 0.71
Alpha 14.46
Beta 0.58
Volatility 40.70%
Current Volume 12.7k
Average Volume 20d 12.3k
What is the price of UG stocks?
As of December 22, 2024, the stock is trading at USD 9.68 with a total of 12,664 shares traded.
Over the past week, the price has changed by -0.81%, over one month by -2.70%, over three months by -33.01% and over the past year by +25.98%.
Is United-Guardian a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, United-Guardian (NASDAQ:UG) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 54.85 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UG as of December 2024 is 9.53. This means that UG is currently overvalued and has a potential downside of -1.55%.
Is UG a buy, sell or hold?
United-Guardian has no consensus analysts rating.
What are the forecast for UG stock price target?
According to ValueRays Forecast Model, UG United-Guardian will be worth about 10.4 in December 2025. The stock is currently trading at 9.68. This means that the stock has a potential upside of +7.13%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.4 7.1%